Примери за използване на Dipharma на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
How is Miglustat Dipharma used?
Miglustat Dipharma 100 mg hard capsules.
Other medicines and Miglustat Dipharma.
How has Miglustat Dipharma been studied?
Other information about Miglustat Dipharma.
Miglustat Dipharma is a‘generic medicine'.
If you stop taking Miglustat Dipharma.
Why is Miglustat Dipharma authorised in the EU?
What are the benefits andrisks of Miglustat Dipharma?
Miglustat Dipharma may make you feel dizzy.
They may lower the amount of Miglustat Dipharma in your body.
Miglustat Dipharma can be taken with or without food.
If you do lose some weight when you start treatment with Miglustat Dipharma don't worry.
Miglustat Dipharma is intended for long-term use.
Your doctor will perform some tests before and during treatment with Miglustat Dipharma to assess this(see section 2).
What is Miglustat Dipharma and what is it used for?
Miglustat Dipharma is available as 100 mg capsules to be taken by mouth.
Until further information is available, before seeking to conceive,male patients should cease Miglustat Dipharma and maintain reliable contraceptive methods for a further 3 months.
Miglustat Dipharma 100 mg hard capsules miglustat.
Until further information is available, it is advised that before seeking to conceive,male patients should cease Miglustat Dipharma and maintain reliable contraceptive methods for 3 months thereafter.
What Miglustat Dipharma is and what it is used for.
Miglustat Dipharma is only used when a patient is considered unsuitable for treatment with enzyme replacement therapy.
He or she may reduce the dose of Miglustat Dipharma or recommend other medicines to help control side effects.
Miglustat Dipharma is used to treat the neurological symptoms of the disease(symptoms affecting the brain and nerves).
An overview of Miglustat Dipharma and why it is authorised in the EU.
Miglustat Dipharma should not be taken during breast-feeding.
You should not take Miglustat Dipharma if you are pregnant or thinking of becoming pregnant.
Miglustat Dipharma received a marketing authorisation valid throughout the EU on 18 February 2019.
Miglustat Dipharma is used to treat the following patients.
Miglustat Dipharma is used to treat mild to moderate type 1 Gaucher disease in adults.